122 related articles for article (PubMed ID: 1305044)
1. Enhancement of macrophage tumouricidal activity by the alkaloid derivative Ukrain. In vitro and in vivo studies.
Sotomayor EM; Rao K; Lopez DM; Liepins A
Drugs Exp Clin Res; 1992; 18 Suppl():5-11. PubMed ID: 1305044
[TBL] [Abstract][Full Text] [Related]
2. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
Liepins A; Nowicky JW
Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
[TBL] [Abstract][Full Text] [Related]
3. Role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. II. Down-regulation of macrophage-mediated cytotoxicity by tumor-derived granulocyte-macrophage colony-stimulating factor.
Sotomayor EM; Fu YX; Lopez-Cepero M; Herbert L; Jimenez JJ; Albarracin C; Lopez DM
J Immunol; 1991 Oct; 147(8):2816-23. PubMed ID: 1918995
[TBL] [Abstract][Full Text] [Related]
4. Ukrain, an alkaloid thiophosphoric acid derivative of Chelidonium majus L. protects human fibroblasts but not human tumour cells in vitro against ionizing radiation.
Cordes N; Plasswilm L; Bamberg M; Rodemann HP
Int J Radiat Biol; 2002 Jan; 78(1):17-27. PubMed ID: 11747550
[TBL] [Abstract][Full Text] [Related]
5. Proapoptotic activity of Ukrain is based on Chelidonium majus L. alkaloids and mediated via a mitochondrial death pathway.
Habermehl D; Kammerer B; Handrick R; Eldh T; Gruber C; Cordes N; Daniel PT; Plasswilm L; Bamberg M; Belka C; Jendrossek V
BMC Cancer; 2006 Jan; 6():14. PubMed ID: 16417634
[TBL] [Abstract][Full Text] [Related]
6. Ukrain (NSC-631570) influences on bone status: a review.
Jabłoński M
Drugs Exp Clin Res; 2000; 26(5-6):317-20. PubMed ID: 11345045
[TBL] [Abstract][Full Text] [Related]
7. Studies concerning the effect of Ukrain in vivo and in vitro.
Brüller W
Drugs Exp Clin Res; 1992; 18 Suppl():13-6. PubMed ID: 1305037
[TBL] [Abstract][Full Text] [Related]
8. Chitotriosidase as a new marker of macrophage stimulation in a tumor model treated with cyclophosphamide and Ukrain.
Korolenko TA; Djanayeva SJ; Falameyeva OV; Wevers RA; Filjushina EE; Buzueva II; Kaledin VI; Sandula J; Nowicky J
Drugs Exp Clin Res; 2000; 26(5-6):279-83. PubMed ID: 11345039
[TBL] [Abstract][Full Text] [Related]
9. Restoration of lipopolysaccharide-mediated cytotoxic macrophage induction in C3H/HeJ mice by interferon-gamma or a calcium ionophore.
Akagawa KS; Kamoshita K; Onodera S; Tokunaga T
Jpn J Cancer Res; 1987 Mar; 78(3):279-87. PubMed ID: 3106284
[TBL] [Abstract][Full Text] [Related]
10. Macrophage stimulation and antitumor effect of Ukrain.
Korolenko TA; Svechnikova IG; Filjushina EE; Kaledin VI; Vakulin GM; Usynin IF; Tsyrendordjiev DD
Drugs Exp Clin Res; 1998; 24(5-6):253-60. PubMed ID: 10190084
[TBL] [Abstract][Full Text] [Related]
11. Ukrain: a novel antitumor drug.
Uglyanitsa KN; Nefyodov LI; Doroshenko YM; Nowicky JW; Volchek IV; Brzosko WJ; Hodysh YJ
Drugs Exp Clin Res; 2000; 26(5-6):341-56. PubMed ID: 11345050
[TBL] [Abstract][Full Text] [Related]
12. Effect of Ukrain on the growth and metastasizing of Lewis carcinoma in C57BL/6 mice.
Grinevich Y; Shalimov S; Bendyuh G; Zahriychuk O; Hodysh Y
Drugs Exp Clin Res; 2005; 31(2):59-70. PubMed ID: 15929607
[TBL] [Abstract][Full Text] [Related]
13. Study of the antitumor effect of Ukrain: the role of macrophage secretion of alpha-1-proteinase inhibitor.
Korolenko TA; Kaledin VI; Svechnikova IG; Li XV; Stashko JF; Ilnitskaya SI; Nikolin VP
Drugs Exp Clin Res; 1998; 24(5-6):271-6. PubMed ID: 10190086
[TBL] [Abstract][Full Text] [Related]
14. Diminished PKC activity and decreased binding of transcription factors are involved in the impaired production of nitric oxide by macrophages from tumor-bearing mice.
Di Napoli MR; Torroella-Kouri M; Perry G; Lopez DM
Int J Mol Med; 2005 Mar; 15(3):503-11. PubMed ID: 15702246
[TBL] [Abstract][Full Text] [Related]
15. Basic central pharmacological properties of thiophosphoric acid alkaloid derivatives from Chelidonium majus L.
Kleinrok Z; Jagiełło-Wójtowicz E; Matuszek B; Chodkowska A
Pol J Pharmacol Pharm; 1992; 44(3):227-39. PubMed ID: 1470561
[TBL] [Abstract][Full Text] [Related]
16. Effect of tumour growth on the macrophage response to the antitumour agent 5,6-dimethylxanthenone-4-acetic acid.
Ching LM; Joseph WR; Baguley BC
Anticancer Res; 1993; 13(6A):2069-75. PubMed ID: 8297115
[TBL] [Abstract][Full Text] [Related]
17. IL-11-induced reduction of C/EBP transcription factor binding may contribute to the IL-12 downregulation in tumor-bearing mice.
Torroella-Kouri M; Keith JC; Ivanova M; Lopez DM
Int J Oncol; 2003 Feb; 22(2):439-48. PubMed ID: 12527946
[TBL] [Abstract][Full Text] [Related]
18. Influence of Ukrain on human xenografts in vitro.
Nowicky JW; Hiesmayr W; Nowicky W; Liepins A
Drugs Exp Clin Res; 1996; 22(3-5):93-7. PubMed ID: 8899310
[TBL] [Abstract][Full Text] [Related]
19. In-vitro toxicity of Ukrain against human Ewing tumor cell lines.
Lanvers-Kaminsky C; Nolting DM; Köster J; Schröder A; Sandkötter J; Boos J
Anticancer Drugs; 2006 Oct; 17(9):1025-30. PubMed ID: 17001175
[TBL] [Abstract][Full Text] [Related]
20. A comparative evaluation of the influence of the complex drug Ukrain and its components on the effects of radiation.
Boyko VN; Zholus RB
Drugs Exp Clin Res; 1998; 24(5-6):331-3. PubMed ID: 10190098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]